| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
662 |
548 |
$116K |
| 80053 |
Comprehensive metabolic panel |
2,219 |
2,003 |
$105K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,544 |
2,207 |
$82K |
| 36415 |
Collection of venous blood by venipuncture |
4,056 |
3,371 |
$44K |
| 84443 |
Thyroid stimulating hormone (TSH) |
981 |
960 |
$33K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
521 |
142 |
$27K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
350 |
338 |
$25K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
210 |
185 |
$24K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
921 |
753 |
$22K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
772 |
712 |
$20K |
| 81001 |
|
926 |
825 |
$19K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
557 |
488 |
$18K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
113 |
113 |
$15K |
| 80061 |
Lipid panel |
343 |
339 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
350 |
312 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
109 |
106 |
$7K |
| 81003 |
|
344 |
338 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
399 |
385 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
255 |
249 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
61 |
50 |
$4K |
| 86140 |
|
99 |
87 |
$3K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
19 |
14 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
16 |
14 |
$2K |
| 87631 |
|
17 |
13 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
69 |
62 |
$2K |
| 87430 |
|
40 |
39 |
$2K |
| 87634 |
|
21 |
20 |
$1K |
| 85027 |
|
72 |
71 |
$1K |
| 87581 |
|
17 |
13 |
$853.10 |
| 87486 |
|
17 |
13 |
$808.40 |
| J3490 |
Unclassified drugs |
42 |
28 |
$683.26 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
17 |
13 |
$599.72 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
15 |
14 |
$533.26 |